Response to: 'Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance'.
Department of Microbiology and Immunology, KU Leuven - University of Leuven, Leuven, Belgium.|Department of Nephrology and Renal Transplantation, University Hospitals Leuven, Leuven, Belgium.
Thomas
0000-0001-5712-6294
T
Vanhove
Drug Delivery and Disposition, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven - University of Leuven, Leuven, Belgium.
Pieter
P
Annaert
Department of Microbiology and Immunology, KU Leuven - University of Leuven, Leuven, Belgium.|Department of Nephrology and Renal Transplantation, University Hospitals Leuven, Leuven, Belgium.
Dirk R J
DRJ
Kuypers
D001835:Body Weight; D051544:Cytochrome P-450 CYP3A / Q000235:genetics*; D005838:Genotype; D006801:Humans; D006888:Hydroxycholesterols; D007166:Immunosuppressive Agents; D016030:Kidney Transplantation; D016559:Tacrolimus
D006888:Hydroxycholesterols; D007166:Immunosuppressive Agents; D051544:Cytochrome P-450 CYP3A; D016559:Tacrolimus
4β-hydroxycholesterol; CYP3A; bodyweight; kidney transplantation; tacrolimus